Are you Dr. Rizzo?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 26 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1250 E Marshall St
Department of Pathology
Richmond, VA 23298Phone+1 804-828-7284Fax+1 804-828-9749
Summary
- Dr. Kathryn Rizzo, DO is a board certified pathologist in Richmond, Virginia. She is currently licensed to practice medicine in Virginia, Idaho, and Tennessee. She is affiliated with Piedmont Columbus Regional Midtown.
Education & Training
National Institutes of Health Clinical CenterFellowship, Cytopathology, 2007 - 2008- National Institutes of Health Clinical CenterFellowship, Hematopathology, 2006 - 2007
Virginia Commonwealth University Health SystemResidency, Pathology-Anatomic and Clinical, 2003 - 2004
Rowan University School of Osteopathic MedicineClass of 2003
Certifications & Licensure
ID State License 2024 - 2026
TN State License 2024 - 2026
SC State License 2011 - 2025
AL State License 2017 - 2024
GA State License 2017 - 2024
NC State License 2014 - 2024
WA State License 2024 - 2024- American Board of Pathology Pathology - Anatomic
- American Board of Pathology Cytopathology
- American Board of Pathology Hematopathology
- Join now to see all
Publications & Presentations
PubMed
- 43 citationsThe NAE inhibitor pevonedistat interacts with the HDAC inhibitor belinostat to target AML cells by disrupting the DDR.Liang Zhou, Shuang Chen, Yu Zhang, Maciej Kmieciak, Yun Leng
Blood. 2016-05-05 - 19 citationsNovel CD19 expression in a peripheral T cell lymphoma: A flow cytometry case report with morphologic correlation.Kathryn Rizzo, Maryalice Stetler-Stevenson, Wyndham H. Wilson, Constance M. Yuan
Cytometry. Part B, Clinical Cytometry. 2009-03-01 - 19 citationsDynamical System Modeling of Immune Reconstitution after Allogeneic Stem Cell Transplantation Identifies Patients at Risk for Adverse Outcomes.Amir A. Toor, Roy T. Sabo, Catherine H. Roberts, Bonny L. Moore, S. R. Salman
Biology of Blood and Marrow Transplantation. 2015-07-01
